| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT07284901 Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With… |
Trial sites expanded: 49 -> 52 locations |
| 2026-05-30 | NCT07458269 Efficacy and Safety of Ribupatide (KAI-9531) Administered Once Weekly in Participants… |
overall status: "Recruiting" → "Enrolling By Invitation" |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07284875 | Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With… | Obesity | Recruiting |
| NCT07284901 | Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With… | Obesity With Diabetes | Recruiting |
| NCT07284979 | Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and… | Obesity | Recruiting |
| Phase 2 | |||
| NCT07458269 | Efficacy and Safety of Ribupatide (KAI-9531) Administered Once Weekly in Participants… | Obesity | Enrolling by Invitation |